

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.89980302 |
| 2 | vocalization behavior (GO:0071625) | 5.71208954 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.50152018 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 4.91702604 |
| 5 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.87611841 |
| 6 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.76366569 |
| 7 | establishment of mitochondrion localization (GO:0051654) | 4.74264118 |
| 8 | neurotransmitter secretion (GO:0007269) | 4.71923053 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.51411861 |
| 10 | auditory behavior (GO:0031223) | 4.48190780 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.41613642 |
| 12 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.38677687 |
| 13 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.28687361 |
| 14 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.24803483 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.22729411 |
| 16 | synaptic vesicle maturation (GO:0016188) | 4.18706732 |
| 17 | neuron recognition (GO:0008038) | 4.14906310 |
| 18 | cell migration in hindbrain (GO:0021535) | 4.14550205 |
| 19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.14532952 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.13753113 |
| 21 | protein localization to synapse (GO:0035418) | 4.08316000 |
| 22 | positive regulation of synapse assembly (GO:0051965) | 4.04167077 |
| 23 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 4.02563309 |
| 24 | mitochondrion transport along microtubule (GO:0047497) | 4.02563309 |
| 25 | neurofilament cytoskeleton organization (GO:0060052) | 3.98159013 |
| 26 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.95828123 |
| 27 | neurotransmitter transport (GO:0006836) | 3.93224448 |
| 28 | neuron-neuron synaptic transmission (GO:0007270) | 3.91208424 |
| 29 | regulation of synaptic vesicle transport (GO:1902803) | 3.88909379 |
| 30 | gamma-aminobutyric acid transport (GO:0015812) | 3.87941799 |
| 31 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.82593053 |
| 32 | locomotory exploration behavior (GO:0035641) | 3.81685379 |
| 33 | glutamate secretion (GO:0014047) | 3.79625415 |
| 34 | postsynaptic membrane organization (GO:0001941) | 3.77778147 |
| 35 | regulation of vesicle fusion (GO:0031338) | 3.76990495 |
| 36 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.74142802 |
| 37 | dendritic spine organization (GO:0097061) | 3.73263607 |
| 38 | regulation of neurotransmitter levels (GO:0001505) | 3.73153423 |
| 39 | proline transport (GO:0015824) | 3.72716058 |
| 40 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.71713288 |
| 41 | presynaptic membrane assembly (GO:0097105) | 3.69469898 |
| 42 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.66931723 |
| 43 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.66931723 |
| 44 | glutamate receptor signaling pathway (GO:0007215) | 3.66737611 |
| 45 | regulation of synapse structural plasticity (GO:0051823) | 3.64713065 |
| 46 | neurotransmitter biosynthetic process (GO:0042136) | 3.64557250 |
| 47 | dendrite morphogenesis (GO:0048813) | 3.64539267 |
| 48 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.63923308 |
| 49 | exploration behavior (GO:0035640) | 3.62303807 |
| 50 | synaptic transmission, glutamatergic (GO:0035249) | 3.62158050 |
| 51 | axon extension (GO:0048675) | 3.61694317 |
| 52 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.56952189 |
| 53 | female mating behavior (GO:0060180) | 3.55693255 |
| 54 | transmission of nerve impulse (GO:0019226) | 3.54114514 |
| 55 | startle response (GO:0001964) | 3.54015646 |
| 56 | regulation of glutamate secretion (GO:0014048) | 3.52828486 |
| 57 | transferrin transport (GO:0033572) | 3.52378892 |
| 58 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.51972554 |
| 59 | mechanosensory behavior (GO:0007638) | 3.50478445 |
| 60 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.49701741 |
| 61 | regulation of female receptivity (GO:0045924) | 3.49512934 |
| 62 | striatum development (GO:0021756) | 3.49246951 |
| 63 | positive regulation of synapse maturation (GO:0090129) | 3.47921728 |
| 64 | opioid receptor signaling pathway (GO:0038003) | 3.47425177 |
| 65 | aggressive behavior (GO:0002118) | 3.46387611 |
| 66 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.45591649 |
| 67 | behavioral response to nicotine (GO:0035095) | 3.44245690 |
| 68 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.43008594 |
| 69 | presynaptic membrane organization (GO:0097090) | 3.42592971 |
| 70 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.39518014 |
| 71 | axonal fasciculation (GO:0007413) | 3.39008495 |
| 72 | negative regulation of microtubule polymerization (GO:0031115) | 3.36293169 |
| 73 | layer formation in cerebral cortex (GO:0021819) | 3.36125640 |
| 74 | synaptic transmission, dopaminergic (GO:0001963) | 3.33378254 |
| 75 | synapse assembly (GO:0007416) | 3.31034047 |
| 76 | positive regulation of amino acid transport (GO:0051957) | 3.29467330 |
| 77 | retinal ganglion cell axon guidance (GO:0031290) | 3.29213842 |
| 78 | ferric iron transport (GO:0015682) | 3.28300994 |
| 79 | trivalent inorganic cation transport (GO:0072512) | 3.28300994 |
| 80 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.28143805 |
| 81 | neuronal action potential propagation (GO:0019227) | 3.26324064 |
| 82 | neuromuscular process controlling posture (GO:0050884) | 3.26102939 |
| 83 | prepulse inhibition (GO:0060134) | 3.26100830 |
| 84 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.25282864 |
| 85 | positive regulation of action potential (GO:0045760) | 3.25059163 |
| 86 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.24414714 |
| 87 | succinate metabolic process (GO:0006105) | 3.24270021 |
| 88 | dendritic spine morphogenesis (GO:0060997) | 3.22726540 |
| 89 | neuron projection extension (GO:1990138) | 3.21780867 |
| 90 | neuronal ion channel clustering (GO:0045161) | 3.18879840 |
| 91 | positive regulation of membrane potential (GO:0045838) | 3.18740892 |
| 92 | response to histamine (GO:0034776) | 3.17221795 |
| 93 | behavioral response to ethanol (GO:0048149) | 3.16543938 |
| 94 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.16158614 |
| 95 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.16158614 |
| 96 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.15575846 |
| 97 | dendrite development (GO:0016358) | 3.14866408 |
| 98 | intraspecies interaction between organisms (GO:0051703) | 3.14611177 |
| 99 | social behavior (GO:0035176) | 3.14611177 |
| 100 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.14125991 |
| 101 | organelle transport along microtubule (GO:0072384) | 3.14062355 |
| 102 | long-term memory (GO:0007616) | 3.13623517 |
| 103 | regulation of protein kinase A signaling (GO:0010738) | 3.12677479 |
| 104 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.12454863 |
| 105 | neuromuscular synaptic transmission (GO:0007274) | 3.12302420 |
| 106 | behavioral fear response (GO:0001662) | 3.11470821 |
| 107 | behavioral defense response (GO:0002209) | 3.11470821 |
| 108 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 3.11382579 |
| 109 | activation of protein kinase A activity (GO:0034199) | 3.11134765 |
| 110 | membrane depolarization during action potential (GO:0086010) | 3.10976895 |
| 111 | synapse organization (GO:0050808) | 3.10674586 |
| 112 | membrane hyperpolarization (GO:0060081) | 3.10466154 |
| 113 | synaptic vesicle endocytosis (GO:0048488) | 3.10170439 |
| 114 | positive regulation of amine transport (GO:0051954) | 3.09797163 |
| 115 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.08827748 |
| 116 | cellular potassium ion homeostasis (GO:0030007) | 3.08715581 |
| 117 | regulation of neurotransmitter uptake (GO:0051580) | 3.08339691 |
| 118 | regulation of synapse assembly (GO:0051963) | 3.05912662 |
| 119 | long-term synaptic potentiation (GO:0060291) | 3.05413182 |
| 120 | neurotransmitter metabolic process (GO:0042133) | 3.04594213 |
| 121 | regulation of postsynaptic membrane potential (GO:0060078) | 3.03677729 |
| 122 | response to cocaine (GO:0042220) | 3.03390830 |
| 123 | mating behavior (GO:0007617) | 3.02763691 |
| 124 | response to auditory stimulus (GO:0010996) | 3.02334765 |
| 125 | axon cargo transport (GO:0008088) | 3.00886285 |
| 126 | glycosphingolipid biosynthetic process (GO:0006688) | 3.00689059 |
| 127 | adult walking behavior (GO:0007628) | 2.99939941 |
| 128 | chaperone-mediated protein transport (GO:0072321) | 2.99843818 |
| 129 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.98179244 |
| 130 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.96862038 |
| 131 | nucleobase catabolic process (GO:0046113) | 2.95639385 |
| 132 | negative regulation of neurotransmitter transport (GO:0051589) | 2.94270786 |
| 133 | dopamine receptor signaling pathway (GO:0007212) | 2.90941922 |
| 134 | membrane depolarization (GO:0051899) | 2.90388168 |
| 135 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.89527747 |
| 136 | regulation of synapse maturation (GO:0090128) | 2.89431147 |
| 137 | regulation of respiratory system process (GO:0044065) | 2.89359102 |
| 138 | regulation of synapse organization (GO:0050807) | 2.87851997 |
| 139 | protein insertion into membrane (GO:0051205) | 2.86578503 |
| 140 | establishment of synaptic vesicle localization (GO:0097480) | 2.85692933 |
| 141 | synaptic vesicle transport (GO:0048489) | 2.85692933 |
| 142 | positive regulation of vesicle fusion (GO:0031340) | 2.80675639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.61852939 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.07029627 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.04487777 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.97777412 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.87286913 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.83240562 |
| 7 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.81435348 |
| 8 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.81129608 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74686257 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.62674040 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.59044915 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53461633 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46017407 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.42379256 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.42379256 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42035220 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.40793963 |
| 18 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.39131185 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31092216 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.29241372 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.25507978 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.23732341 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11981561 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.10982791 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09664086 |
| 26 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.05520475 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.03959581 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.01943114 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.92336615 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.92084312 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.86912778 |
| 32 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.86583969 |
| 33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.85468670 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78190732 |
| 35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.77525189 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.75033083 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.74828415 |
| 38 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74717226 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.74078116 |
| 40 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.67811011 |
| 41 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.64001352 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.63989509 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61128749 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.54095101 |
| 45 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.50595176 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47083367 |
| 47 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46941484 |
| 48 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.45761031 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41546575 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41403672 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40072765 |
| 52 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39949048 |
| 53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38961235 |
| 54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.38798850 |
| 55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.38791092 |
| 56 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36311036 |
| 57 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.35053103 |
| 58 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32193521 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31777356 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.28619573 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27843367 |
| 62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23776233 |
| 63 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.23753293 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.22381200 |
| 65 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19994206 |
| 66 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.17788238 |
| 67 | JUN_21703547_ChIP-Seq_K562_Human | 1.16584375 |
| 68 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16559934 |
| 69 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.16366941 |
| 70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15968567 |
| 71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13082913 |
| 72 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.12301543 |
| 73 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11749620 |
| 74 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11428572 |
| 75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10548372 |
| 76 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.08688956 |
| 77 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.06760005 |
| 78 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.06695278 |
| 79 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.05398046 |
| 80 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03999441 |
| 81 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03496401 |
| 82 | AR_19668381_ChIP-Seq_PC3_Human | 1.03000183 |
| 83 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01912829 |
| 84 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00460169 |
| 85 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99107128 |
| 86 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98931444 |
| 87 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98182628 |
| 88 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.98132554 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96547752 |
| 90 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.95747535 |
| 91 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95090210 |
| 92 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94603548 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94488332 |
| 94 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94186862 |
| 95 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94115568 |
| 96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93174862 |
| 97 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93054434 |
| 98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92532302 |
| 99 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.92284713 |
| 100 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.90869969 |
| 101 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.89568293 |
| 102 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89412267 |
| 103 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89108738 |
| 104 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.88944905 |
| 105 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88944905 |
| 106 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.88920393 |
| 107 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88400328 |
| 108 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87660075 |
| 109 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86948620 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85627086 |
| 111 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.85627086 |
| 112 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85486787 |
| 113 | EWS_26573619_Chip-Seq_HEK293_Human | 0.85217640 |
| 114 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.84979990 |
| 115 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.84957677 |
| 116 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.83452641 |
| 117 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.82218165 |
| 118 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80522763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.59691566 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.25774935 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.61162958 |
| 4 | MP0003122_maternal_imprinting | 3.43155277 |
| 5 | MP0006276_abnormal_autonomic_nervous | 3.26386795 |
| 6 | MP0009745_abnormal_behavioral_response | 3.25374864 |
| 7 | MP0005423_abnormal_somatic_nervous | 3.11863359 |
| 8 | MP0002064_seizures | 3.07520171 |
| 9 | MP0009046_muscle_twitch | 3.05532659 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.99943075 |
| 11 | MP0001529_abnormal_vocalization | 2.97928049 |
| 12 | MP0002822_catalepsy | 2.92771990 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.83936575 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.78685232 |
| 15 | MP0005645_abnormal_hypothalamus_physiol | 2.67981379 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.57501774 |
| 17 | MP0002272_abnormal_nervous_system | 2.43909004 |
| 18 | MP0005646_abnormal_pituitary_gland | 2.40617271 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.37396567 |
| 20 | MP0004270_analgesia | 2.29292655 |
| 21 | MP0002736_abnormal_nociception_after | 2.28317477 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.27967753 |
| 23 | MP0003787_abnormal_imprinting | 2.27620360 |
| 24 | MP0001486_abnormal_startle_reflex | 2.18770618 |
| 25 | MP0002735_abnormal_chemical_nociception | 2.11278484 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.99558678 |
| 27 | MP0001970_abnormal_pain_threshold | 1.93618758 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.91743908 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.90179440 |
| 30 | MP0004142_abnormal_muscle_tone | 1.87707341 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.87631988 |
| 32 | MP0001905_abnormal_dopamine_level | 1.87301517 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.86907450 |
| 34 | MP0004924_abnormal_behavior | 1.86907450 |
| 35 | MP0002184_abnormal_innervation | 1.84539949 |
| 36 | MP0001984_abnormal_olfaction | 1.80212265 |
| 37 | MP0003121_genomic_imprinting | 1.66288327 |
| 38 | MP0000778_abnormal_nervous_system | 1.62641042 |
| 39 | MP0004858_abnormal_nervous_system | 1.62352355 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.50225390 |
| 41 | MP0004811_abnormal_neuron_physiology | 1.48979906 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.45425834 |
| 43 | MP0000751_myopathy | 1.33558353 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.30999952 |
| 45 | MP0000955_abnormal_spinal_cord | 1.30501047 |
| 46 | MP0003329_amyloid_beta_deposits | 1.29625848 |
| 47 | MP0001188_hyperpigmentation | 1.29136853 |
| 48 | MP0003879_abnormal_hair_cell | 1.27370457 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.27125543 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.25967332 |
| 51 | MP0005187_abnormal_penis_morphology | 1.24007768 |
| 52 | MP0003646_muscle_fatigue | 1.21286510 |
| 53 | MP0008569_lethality_at_weaning | 1.20621884 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.17454523 |
| 55 | MP0000569_abnormal_digit_pigmentation | 1.15124254 |
| 56 | MP0001502_abnormal_circadian_rhythm | 1.14332769 |
| 57 | MP0010386_abnormal_urinary_bladder | 1.09017187 |
| 58 | MP0003123_paternal_imprinting | 1.07292512 |
| 59 | MP0008872_abnormal_physiological_respon | 1.05465644 |
| 60 | MP0002653_abnormal_ependyma_morphology | 1.05131981 |
| 61 | MP0002638_abnormal_pupillary_reflex | 1.04803601 |
| 62 | MP0004133_heterotaxia | 1.03579771 |
| 63 | MP0002069_abnormal_eating/drinking_beha | 1.02785924 |
| 64 | MP0000631_abnormal_neuroendocrine_gland | 1.01987736 |
| 65 | MP0002163_abnormal_gland_morphology | 1.00671914 |
| 66 | MP0002152_abnormal_brain_morphology | 0.99806966 |
| 67 | MP0005394_taste/olfaction_phenotype | 0.98655375 |
| 68 | MP0005499_abnormal_olfactory_system | 0.98655375 |
| 69 | MP0003861_abnormal_nervous_system | 0.96907415 |
| 70 | MP0000681_abnormal_thyroid_gland | 0.94012427 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 0.89663163 |
| 72 | MP0003633_abnormal_nervous_system | 0.88500169 |
| 73 | MP0003890_abnormal_embryonic-extraembry | 0.87153029 |
| 74 | MP0008877_abnormal_DNA_methylation | 0.86931195 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 0.86046117 |
| 76 | MP0004742_abnormal_vestibular_system | 0.82990962 |
| 77 | MP0000604_amyloidosis | 0.82142022 |
| 78 | MP0005535_abnormal_body_temperature | 0.81713608 |
| 79 | MP0003938_abnormal_ear_development | 0.81581874 |
| 80 | MP0003631_nervous_system_phenotype | 0.81403795 |
| 81 | MP0000049_abnormal_middle_ear | 0.80881944 |
| 82 | MP0002229_neurodegeneration | 0.80634110 |
| 83 | MP0004085_abnormal_heartbeat | 0.80418004 |
| 84 | MP0002752_abnormal_somatic_nervous | 0.77762090 |
| 85 | MP0001963_abnormal_hearing_physiology | 0.77446946 |
| 86 | MP0004233_abnormal_muscle_weight | 0.77103222 |
| 87 | MP0001664_abnormal_digestion | 0.77047816 |
| 88 | MP0004885_abnormal_endolymph | 0.75474046 |
| 89 | MP0002234_abnormal_pharynx_morphology | 0.75126320 |
| 90 | MP0002751_abnormal_autonomic_nervous | 0.71082461 |
| 91 | MP0000534_abnormal_ureter_morphology | 0.69964080 |
| 92 | MP0003119_abnormal_digestive_system | 0.69362685 |
| 93 | MP0002332_abnormal_exercise_endurance | 0.69265165 |
| 94 | MP0001986_abnormal_taste_sensitivity | 0.68653765 |
| 95 | MP0010770_preweaning_lethality | 0.68548807 |
| 96 | MP0002082_postnatal_lethality | 0.68548807 |
| 97 | MP0001177_atelectasis | 0.67521402 |
| 98 | MP0003634_abnormal_glial_cell | 0.66993943 |
| 99 | MP0001943_abnormal_respiration | 0.66665425 |
| 100 | MP0006072_abnormal_retinal_apoptosis | 0.66514366 |
| 101 | MP0010769_abnormal_survival | 0.66182723 |
| 102 | MP0008995_early_reproductive_senescence | 0.65487296 |
| 103 | MP0008874_decreased_physiological_sensi | 0.64941541 |
| 104 | MP0010768_mortality/aging | 0.63861283 |
| 105 | MP0002081_perinatal_lethality | 0.63821070 |
| 106 | MP0004043_abnormal_pH_regulation | 0.63110646 |
| 107 | MP0006035_abnormal_mitochondrial_morpho | 0.62530008 |
| 108 | MP0005195_abnormal_posterior_eye | 0.61604909 |
| 109 | MP0003942_abnormal_urinary_system | 0.60409924 |
| 110 | MP0002160_abnormal_reproductive_system | 0.59349938 |
| 111 | MP0001919_abnormal_reproductive_system | 0.58463831 |
| 112 | MP0003632_abnormal_nervous_system | 0.58068964 |
| 113 | MP0003690_abnormal_glial_cell | 0.57739783 |
| 114 | MP0000026_abnormal_inner_ear | 0.57625716 |
| 115 | MP0005448_abnormal_energy_balance | 0.57506043 |
| 116 | MP0003283_abnormal_digestive_organ | 0.57203453 |
| 117 | MP0002102_abnormal_ear_morphology | 0.57081859 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.56540332 |
| 119 | MP0000538_abnormal_urinary_bladder | 0.56363179 |
| 120 | MP0004484_altered_response_of | 0.54936123 |
| 121 | MP0004145_abnormal_muscle_electrophysio | 0.52479445 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.52069277 |
| 123 | MP0002090_abnormal_vision | 0.51443660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.36234238 |
| 2 | Myokymia (HP:0002411) | 5.02032517 |
| 3 | Focal seizures (HP:0007359) | 4.75161005 |
| 4 | Polyphagia (HP:0002591) | 4.68053407 |
| 5 | Atonic seizures (HP:0010819) | 4.53452997 |
| 6 | Failure to thrive in infancy (HP:0001531) | 4.50105486 |
| 7 | Visual hallucinations (HP:0002367) | 4.49494559 |
| 8 | Limb dystonia (HP:0002451) | 4.31607585 |
| 9 | Abnormal hair whorl (HP:0010721) | 4.25443058 |
| 10 | Thyroid-stimulating hormone excess (HP:0002925) | 4.18098053 |
| 11 | Febrile seizures (HP:0002373) | 4.10767188 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.99368482 |
| 13 | Absence seizures (HP:0002121) | 3.94739407 |
| 14 | Hyperventilation (HP:0002883) | 3.81343365 |
| 15 | Poor suck (HP:0002033) | 3.73017533 |
| 16 | Abnormal eating behavior (HP:0100738) | 3.66592265 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.63499719 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.56002348 |
| 19 | Dialeptic seizures (HP:0011146) | 3.50395113 |
| 20 | Oligomenorrhea (HP:0000876) | 3.41229520 |
| 21 | Progressive inability to walk (HP:0002505) | 3.39300753 |
| 22 | Pheochromocytoma (HP:0002666) | 3.24359747 |
| 23 | Abnormality of the labia minora (HP:0012880) | 3.23441652 |
| 24 | Gait imbalance (HP:0002141) | 3.15831060 |
| 25 | Broad-based gait (HP:0002136) | 3.08523860 |
| 26 | Acute necrotizing encephalopathy (HP:0006965) | 3.03364566 |
| 27 | Hypoventilation (HP:0002791) | 3.00807245 |
| 28 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.95158237 |
| 29 | Neuroendocrine neoplasm (HP:0100634) | 2.93087542 |
| 30 | Excessive salivation (HP:0003781) | 2.90803453 |
| 31 | Drooling (HP:0002307) | 2.90803453 |
| 32 | Anxiety (HP:0000739) | 2.89697376 |
| 33 | Narrow nasal bridge (HP:0000446) | 2.84359692 |
| 34 | Cortical dysplasia (HP:0002539) | 2.81128749 |
| 35 | Agitation (HP:0000713) | 2.78994979 |
| 36 | Progressive macrocephaly (HP:0004481) | 2.76076562 |
| 37 | Ankle clonus (HP:0011448) | 2.74880437 |
| 38 | Specific learning disability (HP:0001328) | 2.73493957 |
| 39 | Truncal ataxia (HP:0002078) | 2.72011497 |
| 40 | Esotropia (HP:0000565) | 2.69192178 |
| 41 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.69184967 |
| 42 | Congenital primary aphakia (HP:0007707) | 2.67934362 |
| 43 | Neurofibrillary tangles (HP:0002185) | 2.66277559 |
| 44 | Medial flaring of the eyebrow (HP:0010747) | 2.64088502 |
| 45 | Depression (HP:0000716) | 2.64007369 |
| 46 | Spastic tetraplegia (HP:0002510) | 2.62960701 |
| 47 | Hypothermia (HP:0002045) | 2.61354181 |
| 48 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.58873837 |
| 49 | Pachygyria (HP:0001302) | 2.56878119 |
| 50 | Nephrogenic diabetes insipidus (HP:0009806) | 2.53001133 |
| 51 | Mutism (HP:0002300) | 2.52562614 |
| 52 | Hyperthyroidism (HP:0000836) | 2.52135803 |
| 53 | Sleep apnea (HP:0010535) | 2.47808592 |
| 54 | Epileptiform EEG discharges (HP:0011182) | 2.46843179 |
| 55 | Retinal dysplasia (HP:0007973) | 2.46097427 |
| 56 | EEG with generalized epileptiform discharges (HP:0011198) | 2.45926279 |
| 57 | Generalized hypotonia (HP:0001290) | 2.45644822 |
| 58 | Dysdiadochokinesis (HP:0002075) | 2.41446588 |
| 59 | Hypsarrhythmia (HP:0002521) | 2.38259188 |
| 60 | Status epilepticus (HP:0002133) | 2.36788211 |
| 61 | Amblyopia (HP:0000646) | 2.32732737 |
| 62 | Mitochondrial inheritance (HP:0001427) | 2.31648962 |
| 63 | Abnormal social behavior (HP:0012433) | 2.27642612 |
| 64 | Impaired social interactions (HP:0000735) | 2.27642612 |
| 65 | Psychosis (HP:0000709) | 2.26588636 |
| 66 | Supranuclear gaze palsy (HP:0000605) | 2.26554350 |
| 67 | Acute encephalopathy (HP:0006846) | 2.24911354 |
| 68 | Spastic gait (HP:0002064) | 2.22803656 |
| 69 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.22685402 |
| 70 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.22685402 |
| 71 | Protruding tongue (HP:0010808) | 2.22635652 |
| 72 | Poor eye contact (HP:0000817) | 2.19898657 |
| 73 | Abnormality of the corticospinal tract (HP:0002492) | 2.18601129 |
| 74 | Cerebral inclusion bodies (HP:0100314) | 2.17323185 |
| 75 | Urinary urgency (HP:0000012) | 2.16923470 |
| 76 | Hypoplasia of the brainstem (HP:0002365) | 2.16125827 |
| 77 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.16125827 |
| 78 | Abnormality of pain sensation (HP:0010832) | 2.16073878 |
| 79 | Impaired pain sensation (HP:0007328) | 2.16073878 |
| 80 | Genetic anticipation (HP:0003743) | 2.15044696 |
| 81 | Fetal akinesia sequence (HP:0001989) | 2.14380442 |
| 82 | Ulnar claw (HP:0001178) | 2.13543321 |
| 83 | Bradykinesia (HP:0002067) | 2.13530572 |
| 84 | Lower limb muscle weakness (HP:0007340) | 2.12353260 |
| 85 | Blue irides (HP:0000635) | 2.11860543 |
| 86 | Diplopia (HP:0000651) | 2.10498559 |
| 87 | Abnormality of binocular vision (HP:0011514) | 2.10498559 |
| 88 | Genital tract atresia (HP:0001827) | 2.07850935 |
| 89 | Inability to walk (HP:0002540) | 2.07627428 |
| 90 | Abnormality of the lower motor neuron (HP:0002366) | 2.07401030 |
| 91 | Gaze-evoked nystagmus (HP:0000640) | 2.06638401 |
| 92 | Vaginal atresia (HP:0000148) | 2.06442612 |
| 93 | Resting tremor (HP:0002322) | 2.06274908 |
| 94 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.03501485 |
| 95 | Hypoplasia of the corpus callosum (HP:0002079) | 2.02021666 |
| 96 | Cerebral hypomyelination (HP:0006808) | 2.01041271 |
| 97 | Absent speech (HP:0001344) | 2.00552332 |
| 98 | Shoulder girdle muscle weakness (HP:0003547) | 2.00480991 |
| 99 | Akinesia (HP:0002304) | 1.98890890 |
| 100 | Exotropia (HP:0000577) | 1.98215218 |
| 101 | Torticollis (HP:0000473) | 1.96618833 |
| 102 | Hip dysplasia (HP:0001385) | 1.95448945 |
| 103 | Dysmetria (HP:0001310) | 1.94852558 |
| 104 | Papilledema (HP:0001085) | 1.94462285 |
| 105 | Postural instability (HP:0002172) | 1.93994123 |
| 106 | Hemiparesis (HP:0001269) | 1.93794015 |
| 107 | Abnormality of the vocal cords (HP:0008777) | 1.93154090 |
| 108 | Nasal speech (HP:0001611) | 1.91833587 |
| 109 | Focal dystonia (HP:0004373) | 1.89091874 |
| 110 | Abnormality of salivation (HP:0100755) | 1.88939431 |
| 111 | Muscular hypotonia of the trunk (HP:0008936) | 1.87826820 |
| 112 | Myotonia (HP:0002486) | 1.87134253 |
| 113 | CNS hypomyelination (HP:0003429) | 1.86955637 |
| 114 | Action tremor (HP:0002345) | 1.86440591 |
| 115 | Leukodystrophy (HP:0002415) | 1.86248844 |
| 116 | Scanning speech (HP:0002168) | 1.85934234 |
| 117 | Craniofacial dystonia (HP:0012179) | 1.85701588 |
| 118 | Amyotrophic lateral sclerosis (HP:0007354) | 1.85616614 |
| 119 | Poor coordination (HP:0002370) | 1.85221930 |
| 120 | Paraplegia (HP:0010550) | 1.84972245 |
| 121 | Split foot (HP:0001839) | 1.84971592 |
| 122 | Lissencephaly (HP:0001339) | 1.84704419 |
| 123 | Delayed gross motor development (HP:0002194) | 1.84387460 |
| 124 | Generalized myoclonic seizures (HP:0002123) | 1.83893211 |
| 125 | Peripheral hypomyelination (HP:0007182) | 1.82557494 |
| 126 | Intellectual disability, severe (HP:0010864) | 1.82009999 |
| 127 | Dyskinesia (HP:0100660) | 1.81287755 |
| 128 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.80969248 |
| 129 | Inappropriate behavior (HP:0000719) | 1.80369706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.25140958 |
| 2 | NTRK3 | 3.98745880 |
| 3 | MARK1 | 3.86494829 |
| 4 | MAP3K12 | 3.84383664 |
| 5 | MAP3K4 | 3.40560116 |
| 6 | MAP2K7 | 3.15056434 |
| 7 | NTRK2 | 2.91979861 |
| 8 | MINK1 | 2.60504722 |
| 9 | MAP3K9 | 2.55682705 |
| 10 | SIK3 | 2.46375206 |
| 11 | MAP2K4 | 2.05589825 |
| 12 | GRK7 | 1.84170652 |
| 13 | MAPK13 | 1.81703980 |
| 14 | TSSK6 | 1.78011373 |
| 15 | PNCK | 1.76846299 |
| 16 | PLK2 | 1.69568889 |
| 17 | EPHA4 | 1.63845236 |
| 18 | UHMK1 | 1.56764988 |
| 19 | TNIK | 1.53322017 |
| 20 | BCR | 1.51196602 |
| 21 | TRIM28 | 1.47882499 |
| 22 | GRK5 | 1.46210212 |
| 23 | PRKCG | 1.43137580 |
| 24 | MAP4K2 | 1.41558330 |
| 25 | ADRBK2 | 1.37837980 |
| 26 | EPHB1 | 1.35654881 |
| 27 | SIK2 | 1.34210647 |
| 28 | PHKG1 | 1.32765971 |
| 29 | PHKG2 | 1.32765971 |
| 30 | CDK5 | 1.30171794 |
| 31 | DAPK1 | 1.26420069 |
| 32 | AKT3 | 1.26295643 |
| 33 | KSR1 | 1.23588712 |
| 34 | ARAF | 1.22985416 |
| 35 | CDK19 | 1.14709344 |
| 36 | CAMK2A | 1.14525139 |
| 37 | PRPF4B | 1.12986536 |
| 38 | NME1 | 1.09089035 |
| 39 | FES | 1.07541745 |
| 40 | EPHA3 | 1.07131688 |
| 41 | WNK3 | 1.05051054 |
| 42 | SGK494 | 1.03597773 |
| 43 | SGK223 | 1.03597773 |
| 44 | DAPK2 | 1.02668450 |
| 45 | CSNK1G2 | 0.98126847 |
| 46 | PAK6 | 0.96550271 |
| 47 | DYRK2 | 0.94925023 |
| 48 | SGK2 | 0.92966345 |
| 49 | ERBB3 | 0.91402853 |
| 50 | TNK2 | 0.90857958 |
| 51 | PRKCE | 0.90482948 |
| 52 | NTRK1 | 0.89699050 |
| 53 | CAMK2B | 0.89529831 |
| 54 | CDK18 | 0.86626453 |
| 55 | CSNK1G3 | 0.85003547 |
| 56 | OXSR1 | 0.84591047 |
| 57 | PAK3 | 0.81597247 |
| 58 | MAP3K11 | 0.79492257 |
| 59 | CDK14 | 0.79454662 |
| 60 | BMPR1B | 0.78614495 |
| 61 | DYRK1B | 0.78467310 |
| 62 | ADRBK1 | 0.76685408 |
| 63 | TYRO3 | 0.74591365 |
| 64 | LIMK1 | 0.74511375 |
| 65 | CDK15 | 0.74158139 |
| 66 | LATS2 | 0.70829382 |
| 67 | RPS6KA2 | 0.68912979 |
| 68 | DYRK1A | 0.67848259 |
| 69 | DYRK3 | 0.67474290 |
| 70 | CAMK1 | 0.67185647 |
| 71 | CAMK2G | 0.65886654 |
| 72 | ERBB4 | 0.65650917 |
| 73 | PRKCH | 0.64990716 |
| 74 | FER | 0.63419823 |
| 75 | PRKD3 | 0.61530873 |
| 76 | CDK11A | 0.61200291 |
| 77 | CAMK2D | 0.61081395 |
| 78 | BRAF | 0.60618329 |
| 79 | WNK4 | 0.59144822 |
| 80 | MYLK | 0.58883341 |
| 81 | PKN1 | 0.55544449 |
| 82 | SGK3 | 0.54724603 |
| 83 | CAMKK1 | 0.50887475 |
| 84 | MAP3K6 | 0.50195350 |
| 85 | SGK1 | 0.49945469 |
| 86 | LMTK2 | 0.48210629 |
| 87 | IRAK2 | 0.47621576 |
| 88 | KSR2 | 0.46665227 |
| 89 | CSNK1E | 0.45826914 |
| 90 | INSRR | 0.45501380 |
| 91 | STK11 | 0.44686655 |
| 92 | MARK2 | 0.44539274 |
| 93 | ROCK2 | 0.42392226 |
| 94 | YES1 | 0.42205063 |
| 95 | PRKCZ | 0.41922012 |
| 96 | CSNK1G1 | 0.41762691 |
| 97 | PRKACA | 0.41067671 |
| 98 | STK38 | 0.40463232 |
| 99 | RPS6KA3 | 0.40320257 |
| 100 | PRKCB | 0.40167423 |
| 101 | MAP3K5 | 0.40004188 |
| 102 | CSNK1D | 0.39873660 |
| 103 | TESK1 | 0.39655102 |
| 104 | RET | 0.39315965 |
| 105 | RPS6KB1 | 0.38991281 |
| 106 | EPHB2 | 0.38669132 |
| 107 | FGR | 0.37788546 |
| 108 | ROCK1 | 0.37637248 |
| 109 | MAPK12 | 0.37307155 |
| 110 | PINK1 | 0.36681949 |
| 111 | CAMK4 | 0.36554068 |
| 112 | PDK4 | 0.35641786 |
| 113 | PDK3 | 0.35641786 |
| 114 | CSNK1A1L | 0.35585160 |
| 115 | ERBB2 | 0.35513229 |
| 116 | MAPK9 | 0.34721933 |
| 117 | PRKACB | 0.34548446 |
| 118 | PRKG1 | 0.34205233 |
| 119 | CAMKK2 | 0.34175319 |
| 120 | FYN | 0.31535868 |
| 121 | RPS6KA5 | 0.31453624 |
| 122 | MAPKAPK5 | 0.30908391 |
| 123 | CDC42BPA | 0.30402479 |
| 124 | RPS6KA4 | 0.30267826 |
| 125 | PRKAA1 | 0.29953245 |
| 126 | BCKDK | 0.29815810 |
| 127 | CSNK1A1 | 0.29501176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.38161583 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.94201818 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.32644739 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 3.10492309 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.69901679 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.58700464 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.50810836 |
| 8 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.38830151 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.34007024 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.24312613 |
| 11 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.19804117 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.14908293 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09784941 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.06934473 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.01553620 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.95225159 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.92220108 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.91293727 |
| 19 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.90921485 |
| 20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.80796075 |
| 21 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.72363236 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.70794532 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69344337 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.60407319 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.58337155 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.55925239 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.55637043 |
| 28 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.48585964 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.41490171 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.39166622 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.37370197 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.34020993 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32437530 |
| 34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.31645929 |
| 35 | Huntingtons disease_Homo sapiens_hsa05016 | 1.30014933 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.20668745 |
| 37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.20421167 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.19375113 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.18134363 |
| 40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.08644951 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.07198134 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06073383 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.05962588 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.04046354 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99963803 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 0.98058441 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.97932075 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96290611 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93056201 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92453349 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82117687 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 0.80722267 |
| 53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76799158 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76494784 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75941597 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75616697 |
| 57 | Alcoholism_Homo sapiens_hsa05034 | 0.75121168 |
| 58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73625999 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71887580 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.69333451 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.67064721 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66498389 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66049186 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65521945 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63122245 |
| 66 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62928920 |
| 67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57669292 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57542574 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57066610 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56025948 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51546427 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51112284 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.49500046 |
| 74 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.48982022 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48087763 |
| 76 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45697587 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44876075 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44533919 |
| 79 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43705294 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43242441 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.42450391 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40710946 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40449941 |
| 84 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40120948 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39467200 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39170385 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38790650 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37275110 |
| 89 | Tight junction_Homo sapiens_hsa04530 | 0.35743959 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35624532 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35597805 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35381447 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.34600798 |
| 94 | Protein export_Homo sapiens_hsa03060 | 0.34239588 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.32089289 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.31343460 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30529175 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.30190946 |
| 99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29905713 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29303649 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29035754 |
| 102 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28462939 |
| 103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.26743902 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26376517 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26040005 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25308690 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24985947 |
| 108 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.24966902 |
| 109 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.24218797 |
| 110 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23336445 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23136410 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22721495 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.22163180 |
| 114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.20787530 |
| 115 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.20197614 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.18966359 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18131134 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18063152 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.17616012 |
| 120 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.16621608 |

